chr1-1041183-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_198576.4(AGRN):c.738C>T(p.Asp246Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00105 in 1,438,034 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 21 hom., cov: 31)
Exomes 𝑓: 0.00029 ( 7 hom. )
Consequence
AGRN
NM_198576.4 synonymous
NM_198576.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.532
Publications
1 publications found
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 8Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 1-1041183-C-T is Benign according to our data. Variant chr1-1041183-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263203.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.532 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00756 (1139/150740) while in subpopulation AFR AF = 0.0262 (1069/40756). AF 95% confidence interval is 0.0249. There are 21 homozygotes in GnomAd4. There are 545 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGRN | NM_198576.4 | c.738C>T | p.Asp246Asp | synonymous_variant | Exon 5 of 36 | ENST00000379370.7 | NP_940978.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGRN | ENST00000379370.7 | c.738C>T | p.Asp246Asp | synonymous_variant | Exon 5 of 36 | 1 | NM_198576.4 | ENSP00000368678.2 |
Frequencies
GnomAD3 genomes AF: 0.00751 AC: 1131AN: 150642Hom.: 20 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1131
AN:
150642
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000746 AC: 50AN: 67026 AF XY: 0.000382 show subpopulations
GnomAD2 exomes
AF:
AC:
50
AN:
67026
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000287 AC: 370AN: 1287294Hom.: 7 Cov.: 33 AF XY: 0.000257 AC XY: 163AN XY: 634806 show subpopulations
GnomAD4 exome
AF:
AC:
370
AN:
1287294
Hom.:
Cov.:
33
AF XY:
AC XY:
163
AN XY:
634806
show subpopulations
African (AFR)
AF:
AC:
250
AN:
24412
American (AMR)
AF:
AC:
25
AN:
22392
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
21658
East Asian (EAS)
AF:
AC:
0
AN:
26858
South Asian (SAS)
AF:
AC:
5
AN:
69730
European-Finnish (FIN)
AF:
AC:
0
AN:
32264
Middle Eastern (MID)
AF:
AC:
7
AN:
4244
European-Non Finnish (NFE)
AF:
AC:
13
AN:
1033216
Other (OTH)
AF:
AC:
70
AN:
52520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00756 AC: 1139AN: 150740Hom.: 21 Cov.: 31 AF XY: 0.00739 AC XY: 545AN XY: 73706 show subpopulations
GnomAD4 genome
AF:
AC:
1139
AN:
150740
Hom.:
Cov.:
31
AF XY:
AC XY:
545
AN XY:
73706
show subpopulations
African (AFR)
AF:
AC:
1069
AN:
40756
American (AMR)
AF:
AC:
54
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3460
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10374
Middle Eastern (MID)
AF:
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4
AN:
67672
Other (OTH)
AF:
AC:
10
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Dec 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Congenital myasthenic syndrome 8 Benign:2
Dec 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.